Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05700396 · ClinicalTrials.gov registry record · NA
Breast Cancer Survivor Educational Intervention
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT05700396: Completed NA study, sponsored by Massachusetts General Hospital.
NCT05700396 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05700396, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
The goal of this study is to test a 6-week virtual education program among Black breast cancer survivors. The virtual program includes sessions on physical activity, goal setting, nutrition, sleep, stress, and social connections.
Primary Outcome
Defined as the number of recruited participants who initiate intervention program.
Interventions
- BEHAVIORAL Breast Cancer Survivor Education Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2023-02-28 |
| Est. Completion | 2023-12-31 |
| Phase | NA |
What the finished NCT05700396 record still lists
NCT05700396 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Breast Cancer Survivor Education Program is the first listed.
NCT05700396 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05700396 about?
NCT05700396 is a clinical study titled "Breast Cancer Survivor Educational Intervention". The goal of this study is to test a 6-week virtual education program among Black breast cancer survivors. The virtual program includes sessions on physical activity, goal setting, nutrition, sleep, stress, and social connections.
What is the current status of trial NCT05700396?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2023-02-28. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT05700396?
The interventions under investigation include: Breast Cancer Survivor Education Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT05700396?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05700396's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI